Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates
Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. – Zacks This quarterly report represents an earnings surprise of 11.54%. A quarter ago, […]